GO:0002296 | T-helper 1 cell lineage commitment | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:0014735 | regulation of muscle atrophy | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:0014736 | negative regulation of muscle atrophy | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:0014744 | positive regulation of muscle adaptation | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:0014745 | negative regulation of muscle adaptation | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:0032231 | regulation of actin filament bundle assembly | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:0032233 | positive regulation of actin filament bundle assembly | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:0051492 | regulation of stress fiber assembly | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:0051496 | positive regulation of stress fiber assembly | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1902669 | positive regulation of axon guidance | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1903796 | negative regulation of inorganic anion transmembrane transport | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904000 | positive regulation of eating behavior | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904054 | regulation of cholangiocyte proliferation | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904056 | positive regulation of cholangiocyte proliferation | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904192 | regulation of cholangiocyte apoptotic process | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904193 | negative regulation of cholangiocyte apoptotic process | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904195 | regulation of granulosa cell proliferation | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904197 | positive regulation of granulosa cell proliferation | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904201 | regulation of iodide transport | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904202 | negative regulation of iodide transport | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904204 | regulation of skeletal muscle hypertrophy | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904206 | positive regulation of skeletal muscle hypertrophy | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904212 | regulation of iodide transmembrane transport | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904213 | negative regulation of iodide transmembrane transport | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:1904690 | positive regulation of cytoplasmic translational initiation | 6.25% (1/16) | 9.67 | 0.001228 | 0.040771 |
GO:0001002 | RNA polymerase III type 1 promoter sequence-specific DNA binding | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:0001003 | RNA polymerase III type 2 promoter sequence-specific DNA binding | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:0002295 | T-helper cell lineage commitment | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:0002360 | T cell lineage commitment | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:0002363 | alpha-beta T cell lineage commitment | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:0031646 | positive regulation of nervous system process | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:0043373 | CD4-positive, alpha-beta T cell lineage commitment | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:0048382 | mesendoderm development | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:0051930 | regulation of sensory perception of pain | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:0051931 | regulation of sensory perception | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:1904059 | regulation of locomotor rhythm | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:2001023 | regulation of response to drug | 6.25% (1/16) | 8.93 | 0.002045 | 0.041346 |
GO:0001025 | RNA polymerase III general transcription initiation factor binding | 6.25% (1/16) | 8.67 | 0.002454 | 0.041489 |
GO:0001156 | TFIIIC-class transcription factor complex binding | 6.25% (1/16) | 8.67 | 0.002454 | 0.041489 |
GO:0014733 | regulation of skeletal muscle adaptation | 6.25% (1/16) | 8.67 | 0.002454 | 0.041489 |
GO:0045670 | regulation of osteoclast differentiation | 6.25% (1/16) | 8.67 | 0.002454 | 0.041489 |
GO:0080084 | 5S rDNA binding | 6.25% (1/16) | 8.67 | 0.002454 | 0.041489 |
GO:0090070 | positive regulation of ribosome biogenesis | 6.25% (1/16) | 8.67 | 0.002454 | 0.041489 |
GO:1903935 | response to sodium arsenite | 6.25% (1/16) | 8.67 | 0.002454 | 0.041489 |
GO:1904036 | negative regulation of epithelial cell apoptotic process | 6.25% (1/16) | 8.67 | 0.002454 | 0.041489 |
GO:0001938 | positive regulation of endothelial cell proliferation | 6.25% (1/16) | 8.08 | 0.003678 | 0.042761 |
GO:0007430 | terminal branching, open tracheal system | 6.25% (1/16) | 8.08 | 0.003678 | 0.042761 |
GO:0010515 | negative regulation of induction of conjugation with cellular fusion | 6.25% (1/16) | 8.08 | 0.003678 | 0.042761 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 6.25% (1/16) | 8.08 | 0.003678 | 0.042761 |
GO:0031931 | TORC1 complex | 6.25% (1/16) | 8.08 | 0.003678 | 0.042761 |
GO:0045792 | negative regulation of cell size | 6.25% (1/16) | 8.08 | 0.003678 | 0.042761 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 6.25% (1/16) | 8.08 | 0.003678 | 0.042761 |
GO:0051729 | germline cell cycle switching, mitotic to meiotic cell cycle | 6.25% (1/16) | 8.08 | 0.003678 | 0.042761 |
GO:0110044 | regulation of cell cycle switching, mitotic to meiotic cell cycle | 6.25% (1/16) | 8.08 | 0.003678 | 0.042761 |
GO:1903998 | regulation of eating behavior | 6.25% (1/16) | 8.08 | 0.003678 | 0.042761 |
GO:0003179 | heart valve morphogenesis | 6.25% (1/16) | 8.45 | 0.002862 | 0.04293 |
GO:0031932 | TORC2 complex | 6.25% (1/16) | 8.45 | 0.002862 | 0.04293 |
GO:0032095 | regulation of response to food | 6.25% (1/16) | 8.45 | 0.002862 | 0.04293 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 6.25% (1/16) | 8.45 | 0.002862 | 0.04293 |
GO:0110045 | negative regulation of cell cycle switching, mitotic to meiotic cell cycle | 6.25% (1/16) | 8.45 | 0.002862 | 0.04293 |
GO:1904688 | regulation of cytoplasmic translational initiation | 6.25% (1/16) | 8.45 | 0.002862 | 0.04293 |
GO:2000253 | positive regulation of feeding behavior | 6.25% (1/16) | 8.45 | 0.002862 | 0.04293 |
GO:0007282 | cystoblast division | 6.25% (1/16) | 7.8 | 0.004494 | 0.043536 |
GO:0010831 | positive regulation of myotube differentiation | 6.25% (1/16) | 7.8 | 0.004494 | 0.043536 |
GO:0038201 | TOR complex | 6.25% (1/16) | 7.8 | 0.004494 | 0.043536 |
GO:0048142 | germarium-derived cystoblast division | 6.25% (1/16) | 7.8 | 0.004494 | 0.043536 |
GO:0055023 | positive regulation of cardiac muscle tissue growth | 6.25% (1/16) | 7.8 | 0.004494 | 0.043536 |
GO:0060421 | positive regulation of heart growth | 6.25% (1/16) | 7.8 | 0.004494 | 0.043536 |
GO:0099547 | regulation of translation at synapse, modulating synaptic transmission | 6.25% (1/16) | 7.8 | 0.004494 | 0.043536 |
GO:0140243 | regulation of translation at synapse | 6.25% (1/16) | 7.8 | 0.004494 | 0.043536 |
GO:0000182 | rDNA binding | 6.25% (1/16) | 7.67 | 0.004902 | 0.043832 |
GO:0031641 | regulation of myelination | 6.25% (1/16) | 7.67 | 0.004902 | 0.043832 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 6.25% (1/16) | 7.67 | 0.004902 | 0.043832 |
GO:0034064 | Tor2-Mei2-Ste11 complex | 6.25% (1/16) | 7.67 | 0.004902 | 0.043832 |
GO:0038202 | TORC1 signaling | 6.25% (1/16) | 7.67 | 0.004902 | 0.043832 |
GO:0051728 | cell cycle switching, mitotic to meiotic cell cycle | 6.25% (1/16) | 7.67 | 0.004902 | 0.043832 |
GO:0060252 | positive regulation of glial cell proliferation | 6.25% (1/16) | 7.67 | 0.004902 | 0.043832 |
GO:2000234 | positive regulation of rRNA processing | 6.25% (1/16) | 7.67 | 0.004902 | 0.043832 |
GO:1903959 | regulation of anion transmembrane transport | 12.5% (2/16) | 4.83 | 0.002218 | 0.043893 |
GO:0031529 | ruffle organization | 6.25% (1/16) | 8.25 | 0.00327 | 0.044078 |
GO:0035176 | social behavior | 6.25% (1/16) | 8.25 | 0.00327 | 0.044078 |
GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process | 6.25% (1/16) | 8.25 | 0.00327 | 0.044078 |
GO:0045945 | positive regulation of transcription by RNA polymerase III | 6.25% (1/16) | 8.25 | 0.00327 | 0.044078 |
GO:0060048 | cardiac muscle contraction | 6.25% (1/16) | 8.25 | 0.00327 | 0.044078 |
GO:1902661 | positive regulation of glucose mediated signaling pathway | 6.25% (1/16) | 8.25 | 0.00327 | 0.044078 |
GO:1903795 | regulation of inorganic anion transmembrane transport | 6.25% (1/16) | 8.25 | 0.00327 | 0.044078 |
GO:0000992 | RNA polymerase III cis-regulatory region sequence-specific DNA binding | 6.25% (1/16) | 7.55 | 0.005309 | 0.044084 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 6.25% (1/16) | 7.55 | 0.005309 | 0.044084 |
GO:0060184 | cell cycle switching | 6.25% (1/16) | 7.55 | 0.005309 | 0.044084 |
GO:0060259 | regulation of feeding behavior | 6.25% (1/16) | 7.55 | 0.005309 | 0.044084 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade | 6.25% (1/16) | 7.55 | 0.005309 | 0.044084 |
GO:0106057 | negative regulation of calcineurin-mediated signaling | 6.25% (1/16) | 7.55 | 0.005309 | 0.044084 |
GO:1901838 | positive regulation of transcription of nucleolar large rRNA by RNA polymerase I | 6.25% (1/16) | 7.55 | 0.005309 | 0.044084 |
GO:1904407 | positive regulation of nitric oxide metabolic process | 6.25% (1/16) | 7.55 | 0.005309 | 0.044084 |
GO:0009745 | sucrose mediated signaling | 6.25% (1/16) | 7.93 | 0.004086 | 0.044709 |
GO:0060446 | branching involved in open tracheal system development | 6.25% (1/16) | 7.93 | 0.004086 | 0.044709 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 6.25% (1/16) | 7.93 | 0.004086 | 0.044709 |
GO:1901355 | response to rapamycin | 6.25% (1/16) | 7.93 | 0.004086 | 0.044709 |
GO:1902659 | regulation of glucose mediated signaling pathway | 6.25% (1/16) | 7.93 | 0.004086 | 0.044709 |
GO:0012501 | programmed cell death | 18.75% (3/16) | 3.16 | 0.004186 | 0.044749 |
GO:0044070 | regulation of anion transport | 12.5% (2/16) | 4.52 | 0.003373 | 0.044807 |
GO:0010506 | regulation of autophagy | 12.5% (2/16) | 4.37 | 0.004154 | 0.044917 |
GO:0016303 | 1-phosphatidylinositol-3-kinase activity | 6.25% (1/16) | 9.25 | 0.001636 | 0.046116 |
GO:0035004 | phosphatidylinositol 3-kinase activity | 6.25% (1/16) | 9.25 | 0.001636 | 0.046116 |
GO:0090335 | regulation of brown fat cell differentiation | 6.25% (1/16) | 9.25 | 0.001636 | 0.046116 |
GO:0120270 | regulation of nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts | 6.25% (1/16) | 9.25 | 0.001636 | 0.046116 |
GO:1904058 | positive regulation of sensory perception of pain | 6.25% (1/16) | 9.25 | 0.001636 | 0.046116 |
GO:0042060 | wound healing | 6.25% (1/16) | 7.45 | 0.005716 | 0.046228 |
GO:0050882 | voluntary musculoskeletal movement | 6.25% (1/16) | 7.45 | 0.005716 | 0.046228 |
GO:1901836 | regulation of transcription of nucleolar large rRNA by RNA polymerase I | 6.25% (1/16) | 7.45 | 0.005716 | 0.046228 |
GO:0000492 | box C/D snoRNP assembly | 6.25% (1/16) | 7.35 | 0.006124 | 0.047065 |
GO:0006359 | regulation of transcription by RNA polymerase III | 6.25% (1/16) | 7.35 | 0.006124 | 0.047065 |
GO:0043610 | regulation of carbohydrate utilization | 6.25% (1/16) | 7.35 | 0.006124 | 0.047065 |
GO:0048714 | positive regulation of oligodendrocyte differentiation | 6.25% (1/16) | 7.35 | 0.006124 | 0.047065 |
GO:0050849 | negative regulation of calcium-mediated signaling | 6.25% (1/16) | 7.35 | 0.006124 | 0.047065 |
GO:0031330 | negative regulation of cellular catabolic process | 12.5% (2/16) | 4.31 | 0.004466 | 0.047199 |
GO:0008219 | cell death | 18.75% (3/16) | 2.93 | 0.006568 | 0.047721 |
GO:0001016 | RNA polymerase III transcription regulatory region sequence-specific DNA binding | 6.25% (1/16) | 7.25 | 0.006531 | 0.047822 |
GO:0007569 | obsolete cell aging | 6.25% (1/16) | 7.25 | 0.006531 | 0.047822 |
GO:0010922 | positive regulation of phosphatase activity | 6.25% (1/16) | 7.25 | 0.006531 | 0.047822 |
GO:0035096 | larval midgut cell programmed cell death | 6.25% (1/16) | 7.25 | 0.006531 | 0.047822 |
GO:0060251 | regulation of glial cell proliferation | 6.25% (1/16) | 7.25 | 0.006531 | 0.047822 |
GO:1900078 | positive regulation of cellular response to insulin stimulus | 6.25% (1/16) | 7.25 | 0.006531 | 0.047822 |
GO:0000491 | small nucleolar ribonucleoprotein complex assembly | 6.25% (1/16) | 7.17 | 0.006937 | 0.048509 |
GO:0030838 | positive regulation of actin filament polymerization | 6.25% (1/16) | 7.17 | 0.006937 | 0.048509 |
GO:0035023 | regulation of Rho protein signal transduction | 6.25% (1/16) | 7.17 | 0.006937 | 0.048509 |
GO:0061050 | regulation of cell growth involved in cardiac muscle cell development | 6.25% (1/16) | 7.17 | 0.006937 | 0.048509 |
GO:0090069 | regulation of ribosome biogenesis | 6.25% (1/16) | 7.17 | 0.006937 | 0.048509 |
GO:0045859 | regulation of protein kinase activity | 12.5% (2/16) | 4.08 | 0.006064 | 0.048617 |
GO:0046579 | positive regulation of Ras protein signal transduction | 6.25% (1/16) | 7.01 | 0.007751 | 0.049034 |
GO:0048713 | regulation of oligodendrocyte differentiation | 6.25% (1/16) | 7.01 | 0.007751 | 0.049034 |
GO:0050687 | negative regulation of defense response to virus | 6.25% (1/16) | 7.01 | 0.007751 | 0.049034 |
GO:0051057 | positive regulation of small GTPase mediated signal transduction | 6.25% (1/16) | 7.01 | 0.007751 | 0.049034 |
GO:1904426 | positive regulation of GTP binding | 6.25% (1/16) | 7.01 | 0.007751 | 0.049034 |
GO:1905099 | positive regulation of guanyl-nucleotide exchange factor activity | 6.25% (1/16) | 7.01 | 0.007751 | 0.049034 |
GO:2001108 | positive regulation of Rho guanyl-nucleotide exchange factor activity | 6.25% (1/16) | 7.01 | 0.007751 | 0.049034 |
GO:0010592 | positive regulation of lamellipodium assembly | 6.25% (1/16) | 7.08 | 0.007344 | 0.049136 |
GO:0045687 | positive regulation of glial cell differentiation | 6.25% (1/16) | 7.08 | 0.007344 | 0.049136 |
GO:0050881 | musculoskeletal movement | 6.25% (1/16) | 7.08 | 0.007344 | 0.049136 |
GO:1902667 | regulation of axon guidance | 6.25% (1/16) | 7.08 | 0.007344 | 0.049136 |
GO:1902745 | positive regulation of lamellipodium organization | 6.25% (1/16) | 7.08 | 0.007344 | 0.049136 |
GO:0001936 | regulation of endothelial cell proliferation | 6.25% (1/16) | 6.93 | 0.008157 | 0.049581 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 6.25% (1/16) | 6.93 | 0.008157 | 0.049581 |
GO:0010591 | regulation of lamellipodium assembly | 6.25% (1/16) | 6.93 | 0.008157 | 0.049581 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 6.25% (1/16) | 6.93 | 0.008157 | 0.049581 |
GO:0070884 | regulation of calcineurin-NFAT signaling cascade | 6.25% (1/16) | 6.93 | 0.008157 | 0.049581 |
GO:1902743 | regulation of lamellipodium organization | 6.25% (1/16) | 6.93 | 0.008157 | 0.049581 |
GO:0043549 | regulation of kinase activity | 12.5% (2/16) | 3.96 | 0.007166 | 0.049734 |